Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
FRAT1
Introduction
Proto-oncogene FRAT1 is a protein that in humans is encoded by the FRAT1 gene.[1][2]
The protein encoded by this gene belongs to the GSK-3-binding protein family. It may function in tumor progression and in lymphomagenesis.[2]
References
References
- ↑ Jonkers J, Korswagen HC, Acton D, Breuer M, Berns A (Mar 1997). “Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas”. EMBO J. 16 (3): 441–50. doi:10.1093/emboj/16.3.441. PMC 1169648. PMID 9034327.
- ↑ 2.0 2.1 “Entrez Gene: FRAT1 frequently rearranged in advanced T-cell lymphomas”.
Further reading
Further reading
- Li L, Yuan H, Weaver CD, et al. (1999). “Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1”. EMBO J. 18 (15): 4233–40. doi:10.1093/emboj/18.15.4233. PMC 1171499. PMID 10428961.
- Saitoh T, Katoh M (2001). “FRAT1 and FRAT2, clustered in human chromosome 10q24.1 region, are up-regulated in gastric cancer”. Int. J. Oncol. 19 (2): 311–5. doi:10.3892/ijo.19.2.311. PMID 11445844.
- Bax B, Carter PS, Lewis C, et al. (2002). “The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation”. Structure. 9 (12): 1143–52. doi:10.1016/S0969-2126(01)00679-7. PMID 11738041.
- Saitoh T, Mine T, Katoh M (2002). “Molecular cloning and expression of proto-oncogene FRAT1 in human cancer”. Int. J. Oncol. 20 (4): 785–9. doi:10.3892/ijo.20.4.785. PMID 11894125.
- Freemantle SJ, Portland HB, Ewings K, et al. (2002). “Characterization and tissue-specific expression of human GSK-3-binding proteins FRAT1 and FRAT2”. Gene. 291 (1–2): 17–27. doi:10.1016/S0378-1119(02)00594-2. PMID 12095675.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Hino S, Michiue T, Asashima M, Kikuchi A (2003). “Casein kinase I epsilon enhances the binding of Dvl-1 to Frat-1 and is essential for Wnt-3a-induced accumulation of beta-catenin”. J. Biol. Chem. 278 (16): 14066–73. doi:10.1074/jbc.M213265200. PMID 12556519.
- Khambata-Ford S, Liu Y, Gleason C, et al. (2003). “Identification of promoter regions in the human genome by using a retroviral plasmid library-based functional reporter gene assay”. Genome Res. 13 (7): 1765–74. doi:10.1101/gr.529803. PMC 403750. PMID 12805274.
- Deloukas P, Earthrowl ME, Grafham DV, et al. (2004). “The DNA sequence and comparative analysis of human chromosome 10”. Nature. 429 (6990): 375–81. doi:10.1038/nature02462. PMID 15164054.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Wang Y, Hewitt SM, Liu S, et al. (2006). “Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumours”. Br. J. Cancer. 94 (5): 686–91. doi:10.1038/sj.bjc.6602988. PMC 2361213. PMID 16479254.
- Hagen T, Cross DA, Culbert AA, et al. (2007). “FRAT1, a substrate-specific regulator of glycogen synthase kinase-3 activity, is a cellular substrate of protein kinase A.”. J. Biol. Chem. 281 (46): 35021–9. doi:10.1074/jbc.M607003200. PMID 16982607.
External links
External links
- FRAT1 human gene location in the UCSC Genome Browser.
- FRAT1 human gene details in the UCSC Genome Browser.